Kenvue Inc. (NYSE:KVUE) saw shares plummet to an all-time low after President Trump linked autism to Tylenol use during pregnancy, causing a 7.47% drop to $16.97 apiece. Trump’s anti-vaccine stance and call for avoiding Tylenol prompted Kenvue Inc. to defend its product, citing scientific evidence refuting the claim.

Read more at Yahoo Finance: Kenvue (KVUE) Falls to New All-Time Low as Trump Hits Tylenol